Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer
- Author
- JESKE, Stephanie1 ; TAGAWA, Scott T1 ; OLOWOKURE, Olugbenga2 ; SELZER, Jodi1 ; GIANNAKAKOU, Paraskevi1 ; NANUS, David M1
[1] Division of Hernatology and Medical Oncology, Weill Cornell Medical College, New York, NY 10065, United States
[2] Division of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, NY 10029, United States - Source
Urologic oncology. 2011, Vol 29, Num 6, pp 676-681, 6 p ; ref : 34 ref
- ISSN
- 1078-1439
- Scientific domain
- Medical oncology; Urology, nephrology
- Publisher
- Elsevier, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- Carboplatin Castrate resistant Chemotherapy Docetaxel Metastatic Paclitaxel Prostate cancer
- Keyword (fr)
- Adulte Anticancéreux Association médicamenteuse Cancer de la prostate Cancérologie Carboplatine Chimiothérapie Docétaxel Homme Mâle Métastase Métastatique Néphrologie Paclitaxel Résistance Stade avancé Traitement Urologie Antimitotique Cancer Dérivé du taxane Pathologie de l'appareil génital mâle Pathologie de l'appareil urinaire Pathologie de la prostate Platine II Complexe Tumeur maligne
- Keyword (en)
- Adult Antineoplastic agent Drug combination Prostate cancer Cancerology Carboplatin Chemotherapy Docetaxel Human Male Metastasis Metastatic Nephrology Paclitaxel Resistance Advanced stage Treatment Urology Antimitotic Cancer Taxane derivatives Male genital diseases Urinary system disease Prostate disease Platinum II Complexes Malignant tumor
- Keyword (es)
- Adulto Anticanceroso Asociación medicamentosa Cáncer de la próstata Cancerología Carboplatino Quimioterapia Docetaxel Hombre Macho Metástasis Metastásico Nefrología Paclitaxel Resistencia Estadio avanzado Tratamiento Urología Antimitótico Cáncer Taxane derivado Aparato genital macho patología Aparato urinario patología Prostata patología Platino II Complejo Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases / 002B14D Tumors of the urinary system / 002B14D02 Urinary tract. Prostate gland
- Discipline
- Nephrology. Urinary tract diseases Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 25229508
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.urolonc.2009.12.023 
https://dx.doi.org/10.1016/j.urolonc.2009.12.023
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.urolonc.2009.12.023\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:109:\"Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:17:\"Urologic oncology\";s:9:\"\u0000*\u0000stitle\";s:11:\"Urol. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"676\";s:8:\"\u0000*\u0000epage\";s:3:\"681\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-1439\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"JESKE\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Stephanie\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:15:\"TAGAWA, Scott T\";i:1;s:20:\"OLOWOKURE, Olugbenga\";i:2;s:12:\"SELZER, Jodi\";i:3;s:22:\"GIANNAKAKOU, Paraskevi\";i:4;s:14:\"NANUS, David M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:109:\"Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.urolonc.2009.12.023\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:109:\"Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:17:\"Urologic oncology\";s:9:\"\u0000*\u0000stitle\";s:11:\"Urol. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"676\";s:8:\"\u0000*\u0000epage\";s:3:\"681\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-1439\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"JESKE\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Stephanie\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:15:\"TAGAWA, Scott T\";i:1;s:20:\"OLOWOKURE, Olugbenga\";i:2;s:12:\"SELZER, Jodi\";i:3;s:22:\"GIANNAKAKOU, Paraskevi\";i:4;s:14:\"NANUS, David M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:109:\"Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.urolonc.2009.12.023\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.urolonc.2009.12.023\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:109:\"Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:17:\"Urologic oncology\";s:9:\"\u0000*\u0000stitle\";s:11:\"Urol. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"676\";s:8:\"\u0000*\u0000epage\";s:3:\"681\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-1439\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"JESKE\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Stephanie\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:15:\"TAGAWA, Scott T\";i:1;s:20:\"OLOWOKURE, Olugbenga\";i:2;s:12:\"SELZER, Jodi\";i:3;s:22:\"GIANNAKAKOU, Paraskevi\";i:4;s:14:\"NANUS, David M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:109:\"Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.urolonc.2009.12.023\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:109:\"Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:17:\"Urologic oncology\";s:9:\"\u0000*\u0000stitle\";s:11:\"Urol. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"676\";s:8:\"\u0000*\u0000epage\";s:3:\"681\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-1439\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"JESKE\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Stephanie\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:15:\"TAGAWA, Scott T\";i:1;s:20:\"OLOWOKURE, Olugbenga\";i:2;s:12:\"SELZER, Jodi\";i:3;s:22:\"GIANNAKAKOU, Paraskevi\";i:4;s:14:\"NANUS, David M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:109:\"Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.urolonc.2009.12.023\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:109:\"Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:17:\"Urologic oncology\";s:9:\"\u0000*\u0000stitle\";s:11:\"Urol. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"676\";s:8:\"\u0000*\u0000epage\";s:3:\"681\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-1439\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"JESKE\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Stephanie\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:15:\"TAGAWA, Scott T\";i:1;s:20:\"OLOWOKURE, Olugbenga\";i:2;s:12:\"SELZER, Jodi\";i:3;s:22:\"GIANNAKAKOU, Paraskevi\";i:4;s:14:\"NANUS, David M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:109:\"Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
